Seeking Alpha

Glenview Capital claims it does not intend to bid for Health Management (HMA +5.2%), which...

Glenview Capital claims it does not intend to bid for Health Management (HMA +5.2%), which recently adopted a poison pill apparently in response to Glenview's conversion of its Schedule 13G filing (disclosing a 14.6% stake) to a Schedule 13D. "We wish to clarify that [we] have made no proposals, either to HMA or to any of its holdings," Glenview says
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector